From the Neuroimmunology and MS Research (NIMS) (C.C., M.P., P.T.O., I.J., M.J.D., R.P., P.M., C.W., I.J., A.L., R.M., M.S.), Department of Neurology, University Hospital and University Zurich, Switzerland; Department of Neuroscience DNS (M.P.), University-Hospital of Padova, Italy; Jung Diagnostics GmbH (R.O.), HIP - Health Innovation Port, Germany; Department of Health Sciences and Technology (C.W.), ETH Zurich, Switzerland; and Clinical Department of Neurology (M.R.), Medical University of Innsbruck, Austria.
Neurol Neuroimmunol Neuroinflamm. 2021 Sep 17;8(6). doi: 10.1212/NXI.0000000000001075. Print 2021 Nov.
Encouraged by the enormous progress that the identification of specific autoantigens added to the understanding of neurologic autoimmune diseases, we undertook here an in-depth study of T-cell specificities in the autoimmune disease multiple sclerosis (MS), for which the spectrum of responsible autoantigens is not fully defined yet. The identification of target antigens in MS is crucial for therapeutic strategies aimed to induce antigen-specific tolerance. In addition, knowledge of relevant T-cell targets can improve our understanding of disease heterogeneity, a hallmark of MS that complicates clinical management.
The proliferative response and interferon gamma (IFN-γ) release of CSF-infiltrating CD4 T cells from patients with MS against several autoantigens was used to identify patients with different intrathecal T-cell specificities. Fresh CSF-infiltrating and paired circulating lymphocytes in these patients were characterized in depth by ex vivo immunophenotyping and transcriptome analysis of relevant T-cell subsets. Further examination of these patients included CSF markers of inflammation and neurodegeneration and a detailed characterization with respect to demographic, clinical, and MRI features.
By testing CSF-infiltrating CD4 T cells from 105 patients with MS against seven long-known myelin and five recently described GDP-l-fucose synthase peptides, we identified GDP-l-fucose synthase and myelin oligodendrocyte glycoprotein (35-55) responder patients. Immunophenotyping of CSF and paired blood samples in these patients revealed a significant expansion of an effector memory (CCR7 CD45RA) CD27 Th1 CD4 cell subset in GDP-l-fucose synthase responders. Subsequent transcriptome analysis of this subset demonstrated expression of Th1 and cytotoxicity-associated genes. Patients with different intrathecal T-cell specificities also differ regarding inflammation- and neurodegeneration-associated biomarkers, imaging findings, expression of HLA class II alleles, and seasonal distribution of the time of the lumbar puncture.
Our observations reveal an association between autoantigen reactivity and features of disease heterogeneity that strongly supports an important role of T-cell specificity in MS pathogenesis. These data have the potential to improve patient classification in clinical practice and to guide the development of antigen-specific tolerization strategies.
由于鉴定特定自身抗原对理解神经自身免疫性疾病的巨大进展,我们在此对自身免疫性疾病多发性硬化症(MS)中的 T 细胞特异性进行了深入研究,因为其负责的自身抗原谱尚未完全定义。在 MS 中鉴定靶抗原对于旨在诱导抗原特异性耐受的治疗策略至关重要。此外,对相关 T 细胞靶标的了解可以提高我们对疾病异质性的理解,这是 MS 的一个标志,使临床管理复杂化。
使用来自 MS 患者的 CSF 浸润性 CD4 T 细胞对几种自身抗原的增殖反应和干扰素 γ(IFN-γ)释放,来鉴定具有不同鞘内 T 细胞特异性的患者。对这些患者的新鲜 CSF 浸润性和配对循环淋巴细胞进行了深入的体外免疫表型和相关 T 细胞亚群的转录组分析。对这些患者的进一步检查包括 CSF 炎症和神经退行性变标志物以及关于人口统计学、临床和 MRI 特征的详细特征。
通过对 105 名 MS 患者的 CSF 浸润性 CD4 T 细胞进行七种已知的髓磷脂和五种最近描述的 GDP-L-岩藻糖合酶肽的测试,我们鉴定出 GDP-L-岩藻糖合酶和髓鞘少突胶质糖蛋白(35-55)应答患者。对这些患者的 CSF 和配对血液样本进行免疫表型分析显示,在 GDP-L-岩藻糖合酶应答者中,效应记忆(CCR7 CD45RA)CD27 Th1 CD4 细胞亚群显著扩增。随后对该亚群的转录组分析表明表达了 Th1 和细胞毒性相关基因。具有不同鞘内 T 细胞特异性的患者在炎症和神经退行性变相关生物标志物、影像学发现、HLA Ⅱ类等位基因表达以及腰椎穿刺时间的季节性分布方面也存在差异。
我们的观察结果揭示了自身抗原反应与疾病异质性特征之间的关联,这强烈支持 T 细胞特异性在 MS 发病机制中的重要作用。这些数据有可能改善临床实践中的患者分类,并指导抗原特异性耐受策略的发展。